Skip to content

Investigating and comparing the therapeutic outcomes of two regimens of cholestin therapy through a bronchoscope versus standard treatment in patients with lung infection

Investigating and comparing the therapeutic outcomes of two treatment regimens of cholestin instillation (through the bronchoscope) versus standard treatment in patients with ventilator-associated pneumonia (VAP) with resistant gram-negative bacilli.

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20120527009886N3
Enrollment
20
Registered
2023-04-11
Start date
2023-04-18
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator Associated Pneumonia. Ventilator associated pneumonia

Interventions

Intervention 1: Intervention group: Instillation Bronchoscopy. Intervention 2: Control group: Clostin nebulizer.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients with ventilator-associated pneumonia Age between 18 and 75 years Patients who developed pulmonary infection with gram-negative bacilli resistant to several antibiotic drugs after 48 hours of intubation.

Exclusion criteria

Exclusion criteria: Age older than 75 or younger than 18 years Patients with adult respiratory distress syndrome (ARDS) according to the Berlin criteria P/F ratio less than 100 Septic shock requires a dose of norepinephrine with a dose greater than 0.25 Mcg/KG/MIN Patients with infection with other microorganisms

Design outcomes

Primary

MeasureTime frame
Mortality rate. Timepoint: After the start of treatment until the discharge or death of the patient. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
The number of days hospitalized in the intensive care unit. Timepoint: After initiation of treatment until discharge or death from the intensive care unit. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMostafa Mohammadi

Tehran University of Medical Sciences

mohammady_mm@tums.ac.ir0098.21.61190

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026